Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/30/17
End: 08/31/20
Due: 08/31/21
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 06/04/19
End: 11/27/20
Due: 11/27/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) | NCT03274206 | BioLeaders Corporation | user2@example.com | None | 2017-08-30 | 2020-08-31 | 2021-08-31 | - | - | 2025-07-14 |
| Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia | NCT01826045 | BioLeaders Corporation | user2@example.com | None | 2013-06-30 | 2016-01-31 | 2017-01-31 | - | - | 2025-07-14 |
| Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) | NCT02195089 | BioLeaders Corporation | user2@example.com | None | 2014-03-31 | 2016-04-30 | 2017-04-30 | - | - | 2025-07-14 |
| Safety Study of BLS-M22 in Healthy Volunteers | NCT03789734 | BioLeaders Corporation | user2@example.com | None | 2019-06-04 | 2020-11-27 | 2021-11-27 | - | - | 2025-07-14 |